Comparison of the monocyte-to-HDL cholesterol ratio between patients with STEMI and NSTEMI: A retrospective observational study

Abdullah Algın 1 2, Serdar Özdemir 1 *
More Detail
1 University of Health Sciences Turkey, Ümraniye Training and Research Hospital, Clinic of Emergency Medicine, İstanbul, Turkey
2 University of Health Sciences Turkey, Somalia Mogadishu Recep Tayyip Erdogan Faculty of Health Sciences, Mogadishu, Somalia
* Corresponding Author
J CLIN MED KAZ, Volume 18, Issue 6, pp. 45-49.
OPEN ACCESS 795 Views 533 Downloads
Download Full Text (PDF)


This study sought to compare patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in terms of the monocyte-to-HDL cholesterol ratio.
Materials and Methods
A total of 79 patients with non-ST-segment elevation myocardial infarction and 30 patients with 30 ST-segment elevation myocardial infarction were included in the study. Demographics, comorbidities, smoking status, medical history, and initial laboratory findings were retrospectively noted from the hospital computer-based patient data system.
Significant differences were detected between the ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction groups in relation to the neutrophil count [7.27 (6.05-9.05) versus 5.41 (4.26-7.21), p<0.001] and mean platelet volume [9.4 (8.8-10) versus 8.6 (7.3-9.5), p=0.002]. There was no statistically significant difference between the two groups in the term of the monocyte-to-HDL cholesterol ratio [0.016 (0.012-0.021) versus 0.016 (0.011-0.024), p=0.757, Bonferroni-corrected p value: 0.0033)].
Based on the results of our study, the monocyte-to-HDL cholesterol ratio did not significantly differ between the patients with ST-segment elevation myocardial infarction and those with non-ST-segment elevation myocardial infarction.


Algın A, Özdemir S. Comparison of the monocyte-to-HDL cholesterol ratio between patients with STEMI and NSTEMI: A retrospective observational study. J CLIN MED KAZ. 2021;18(6):45-9.


  • Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc. 2009;84(10):917-938. doi:10.1016/S0025-6196(11)60509-0
  • Lindahl B. Acute coronary syndrome - the present and future role of biomarkers. Clin Chem Lab Med. 2013;51(9):1699-706. doi: 10.1515/cclm-2013-0074. PMID: 23525876.
  • Akça HŞ, Algın A, Özdemir S, Altunok İ, Acar Kurtuluş S, Eroğlu SE. Effect of Baseline RDW and Troponin Levels on Prognosis in Patients with Acute Chest Pain. Signa Vitae. 2020;16(2):97-103.
  • Özkan A, Sönmez E, Özdemir S, Özer ÖF, Muharrem N, Gülen B, Keskin M. The Diagnostic Value of SCUBE1 in Unstable Angina Pectoris Patients. Eurasian J Emerg Med. 2016;15:167-171.
  • Algın A, Akça HŞ, Özdemir S, Afacan MA, Eroğlu SE. Analysis of Relationship Between Imaging Features of Aortic Dissection and Blood Parameters. Med Bull Haseki. 2020;58:193-9.
  • Salvagno GL, Pavan C. Prognostic biomarkers in acute coronary syndrome. Ann Transl Med. 2016;4(13):258. doi:10.21037/atm.2016.06.36
  • Cetin MS, Ozcan Cetin EH, Kalender E, et al. Monocyte to HDL Cholesterol Ratio Predicts Coronary Artery Disease Severity and Future Major Cardiovascular Adverse Events in Acute Coronary Syndrome. Heart Lung Circ. 2016;25(11):1077-1086. doi: 10.1016/j.hlc.2016.02.023. Epub 2016 Apr 12. PMID: 27118231.
  • Canpolat U, Çetin EH, Cetin S, et al. Association of Monocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic Inflammation. Clin Appl Thromb. Hemost. 2016;22(5):476-82. doi: 10.1177/1076029615594002. Epub 2015 Jul 1. PMID: 26139836.
  • Kanbay M, Solak Y, Unal HU, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2014; 46(8):1619-25. doi: 10.1007/s11255-014-0730-1. Epub 2014 May 23. PMID: 24853998.
  • Arısoy A, Altunkaş F, Karaman K, et al. Association of the Monocyte to HDL Cholesterol Ratio with Thrombus Burden in Patients With ST-Segment Elevation Myocardial Infarction. Clin Appl Thromb Hemost. 2017;23(8):992-997. doi: 10.1177/1076029616663850. Epub 2016 Aug 16. PMID: 27534422.
  • Kızıltunç E, Alsancak Y, Sezenöz B, et al. Relationship Between Monocyte/High-Density Lipoprotein Cholesterol Ratio and Angiographic Severity and Extent of Coronary Artery Disease. Koşuyolu Heart Journal. 2017; 20(1): 30-5.
  • Lambert JM, Lopez EF, Lindsey ML. Macrophage roles following myocardial infarction. Int J Cardiol. 2008;130(2):147-158. doi:10.1016/j.ijcard.2008.04.059
  • Demir A, Eren F. Akut İskemik İnmeli Hastalarda, İnmenin Ciddiyeti İle Monosit/HDL-K Arasındaki İlişki. CBU-SBED. 2020; 7(4): 443-447.
  • Choi SH, Kim JH, Lim S, Lim JY, Kim KW, Park KS, Jang HC. Monocyte count as a predictor of cardiovascular mortality in older Korean people. Age Ageing. 2017;46(3):433-438. doi: 10.1093/ageing/afw226. PMID: 27932363.
  • Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circulation Research. 2006;98(11):1352-1364. doi: 10.1161/01.res.0000225982.01988.93. PMID: 16763172.
  • Rysz J, Gluba-Brzózka A, Rysz-Górzyńska M, Franczyk B. The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease. Int J Mol Sci. 2020;21(2):601. doi: 10.3390/ijms21020601. PMID: 31963445; PMCID: PMC7014265.
  • Ganjali S, Gotto AM Jr, Ruscica M, Atkin SL, Butler AE, Banach M, Sahebkar A. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol. 2018;233(12):9237-9246. doi: 10.1002/jcp.27028.
  • Chen H, Li M, Liu L, Dang X, Zhu D, Tian G. Monocyte/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients with non-ST-elevation myocardial infarction. Medicine (Baltimore). 2019;98(26):e16267. doi:10.1097/MD.0000000000016267
  • Kalyoncuoglu M, Durmus G. Relationship between C-reactive protein-to-albumin ratio and the extent of coronary artery disease in patients with non-ST-elevated myocardial infarction. Coron Artery Dis. 2020;31(2):130-136. doi: 10.1097/MCA.0000000000000768. PMID: 31233399.